Product Name: CD86 / B7-2 Antibody (FITC), Mouse MAb
Immunogen: Recombinant Human CD86 / B7-2 protein
Mouse IgG1: Mouse IgG1
Concentration: 10 μl/Test, 0.1 mg/ml
Formulation: Aqueous solution containing 0.5% BSA and 0.09% sodium azide
Preparation: This antibody was produced from a hybridoma resulting from the fusion of a mouse myeloma with B cells obtained from a mouse immunized with purified, recombinant Human CD86 / B7-2 and conjugated with FITC under optimum conditions, the unreacted FITC was r
Specificity: Human CD86 / B7-2No cross-reactivity in ELISA withMouse B7-2Human B7-1Human B7-H1Human cell lysate (293 cell line)
Application: FCM
CAS NO.: 68252-19-7
Product: (±)-Pirmenol
Storage: This antibody is stable for 12 months from date of receipt when stored at 2℃-8℃. Protected from prolonged exposure to light. Do not freeze ! Sodium azide is toxic to cells and should be disposed of properly. Flush with large volumes of water during dispos
Caption: Profile of anti-B7-2 (CD86) reactivity on Daudi cells analyzed by flow cytometry. Cells should be Fc-blocked by treatment with 20 μg of human IgG/106 cells for 1 hour at 4 ℃ prior to staining, washed, then stained with FITC Mouse anti-B7-2 (CD86).
Background: CD86, also known as B-lymphocyte activation antigen B7-2 (referred to as B70), is a member of the cell surface immunoglobulin superfamily. B7-2 exists predominantly as a monomer on cell surfaces and interacts with two co-stimulatory receptors CD28 and cyt
PubMed ID:http://jpet.aspetjournals.org/content/190/1/88